Pulse Biosciences, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
Pulse Biosciences, Inc. (PLSE) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $625.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-06
- Pulse Biosciences, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $317.00K, a 12.41% increase year-over-year.
- Pulse Biosciences, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $308.00K, a 12.41% increase year-over-year.
- Pulse Biosciences, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $306.00K, a 20.00% increase year-over-year.
- Pulse Biosciences, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $291.00K, a 26.52% increase year-over-year.
- Pulse Biosciences, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $1.15M, a 24.92% increase from fiscal 2024.
- Pulse Biosciences, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $923.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $317.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $625.00K 10-Q · filed 2026-08-06 | $931.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.22M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $308.00K 10-Q · filed 2026-05-14 | $614.00K derived: sum of 2 quarters · filed 2026-05-14 | $905.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $306.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $597.00K derived: sum of 2 quarters · filed 2026-02-19 | $879.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.15M 10-K · filed 2026-02-19 |
| 2025-09-30 | $291.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $573.00K derived: sum of 2 quarters · filed 2026-08-06 | $847.00K 10-Q · filed 2025-11-05 | $1.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $282.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $556.00K 10-Q · filed 2026-08-06 | $811.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $274.00K 10-Q · filed 2026-05-14 | $529.00K derived: sum of 2 quarters · filed 2026-05-14 | $759.00K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $485.00K derived: sum of 2 quarters · filed 2026-02-19 | $923.00K 10-K · filed 2026-02-19 | |
| 2024-09-30 | $230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $668.00K 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $438.00K 10-Q · filed 2025-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |